AOD-9604 was developed to: Stimulate lipolysis (breakdown of stored fat) Inhibit lipogenesis (formation of new fat) Avoid raising IGF-1 levels Reduce impact on blood glucose Because it is a small fragment rather than the full hormone, it theoretically targets fat metabolism more specifically
Mild tendon injuries may improve more quickly, while chronic or severe injuries may require longer healing periods
Strinic et al., BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in rats, Life Sci., vol
NICE does not currently have guidance on either AOD 9604 or retatrutide, reflecting their unlicensed and investigational status within the UK healthcare system
Whether you're seeking to restore volume, smooth fine lines, or revitalize skin tone, our expert team helps you look as vibrant as you feel